title: Selective restoration of immunosuppressive effect of cytotoxic agents by thymopoietin fragments.
abstract: Swiss male mice were immunosuppressed by cyclophosphamide, cisplatinum, vincristine and methotrexate. The ability of the thymopoietin (TP) fragments TP-3, TP-4 and TP-5 to restore antibody production and phagocytosis was studied. Impaired antibody production after vincristine treatment was partially or totally restored by TP-3, TP-4 or TP-5. Only TP-3 or TP-5 interfered with the antibody-production-damaging effect of cisplatinum. The same effect of methotrexate could not be influenced by any of the TP fragments. The phagocytic capacity of peritoneal macrophages was reduced by vincristine, methotrexate and cyclophosphamide treatment. In this respect, TP-3 protected the function of macrophages against vincristine and cyclophosphamide treatment. TP-4 was active in the case of damage caused by vincristine and methotrexate, and TP-5 interfered with the phagocytosis-inhibiting effect of methotrexate. Each TP fragment seems to have a specific target orientation within the immune system. This also means that the proper TP fragment should always be chosen for combination therapy with various types of cytotoxic drugs.
authors.affiliation: Chemical Works of Gedeon Richter Ltd., Budapest, Hungary.
authors.forename: L
authors.initials: L
authors.lastname: Dénes
authors.forename: B
authors.initials: B
authors.lastname: Szende
authors.forename: G
authors.initials: G
authors.lastname: Hajós
authors.forename: L
authors.initials: L
authors.lastname: Szporny
authors.forename: K
authors.initials: K
authors.lastname: Lapis
mesh_terms: D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects; D004912:Erythrocytes / Q000276:immunology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D051379:Mice; D010446:Peptide Fragments / Q000494:pharmacology*; D010587:Phagocytosis / Q000187:drug effects; D012756:Sheep; D013601:T-Lymphocytes / Q000276:immunology; D013946:Thymopoietins / Q000494:pharmacology*; D014750:Vincristine / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D010446:Peptide Fragments; D013946:Thymopoietins; D014750:Vincristine; D002945:Cisplatin; D008727:Methotrexate